- Home
- RCKT vs EVCM Comparison
RCKT vs EVCM Comparison
Compare RCKT & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- EVCM
- Stock Information
- Founded
- RCKT 1999
- EVCM 2006
- Country
- RCKT United States
- EVCM United States
- Employees
- RCKT N/A
- EVCM N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- EVCM EDP Services
- Sector
- RCKT Health Care
- EVCM Technology
- Exchange
- RCKT Nasdaq
- EVCM Nasdaq
- Market Cap
- RCKT 328.6M
- EVCM 2.2B
- IPO Year
- RCKT N/A
- EVCM 2021
- Fundamental
- Price
- RCKT $3.25
- EVCM $11.72
- Analyst Decision
- RCKT Buy
- EVCM Buy
- Analyst Count
- RCKT 13
- EVCM 9
- Target Price
- RCKT $12.96
- EVCM $11.89
- AVG Volume (30 Days)
- RCKT 5.7M
- EVCM 240.5K
- Earning Date
- RCKT 11-06-2025
- EVCM 11-11-2025
- Dividend Yield
- RCKT N/A
- EVCM N/A
- EPS Growth
- RCKT N/A
- EVCM N/A
- EPS
- RCKT N/A
- EVCM N/A
- Revenue
- RCKT N/A
- EVCM $710,678,000.00
- Revenue This Year
- RCKT N/A
- EVCM N/A
- Revenue Next Year
- RCKT $108.43
- EVCM $5.95
- P/E Ratio
- RCKT N/A
- EVCM N/A
- Revenue Growth
- RCKT N/A
- EVCM 14.15
- 52 Week Low
- RCKT $2.19
- EVCM $8.10
- 52 Week High
- RCKT $22.01
- EVCM $12.34
- Technical
- Relative Strength Index (RSI)
- RCKT 51.65
- EVCM 57.34
- Support Level
- RCKT N/A
- EVCM $11.23
- Resistance Level
- RCKT $3.30
- EVCM $11.75
- Average True Range (ATR)
- RCKT 0.16
- EVCM 0.33
- MACD
- RCKT -0.13
- EVCM 0.03
- Stochastic Oscillator
- RCKT 86.92
- EVCM 64.00
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.